Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma

Conditions:   Laryngeal Cancer;   Hypopharynx Cancer;   Laryngeal Neoplasms Intervention:   Drug: chemotherapy TP regimen combined with Toripalimab Sponsor:   Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials